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Elsewhere in Biology 
Chosen and summarized by the staff of Chemistry & Biology 
Current Bidogy Ltd has launched a new journal 
entftled Current Opinion in Chemical Bcology, whkh 
wilt be of partfcular interest to readers of Chemistry & 
Sio/agy. The editors of the journal are Donald Milvert 
and Steven V f&y. The fourth Issue, on modef systems 
(edited by Julius Rebel Jr and David N Refnhoudt) and 
blopolymers (edlted by Anne Dell, Barbara Imperiali 
and Carry WLaughfSn) is pubfished in December. 
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A selection of interesting papers published last month 
in Chemistry & Biology’s sister journals, Current 
Biology, Folding & Design and Structure. 
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0 Janus kinases in interleukin-2.mediated signaling: 
JAKl and JAK3 are differentially regulated by 
tyrosine phosphotyiation. Kathleen D Liu, Sarah L 
Gaffen, Mark A Goldsmith and Warner C Greene (1997). 
Cur. Biol. 7, 817-826. 
Cytokines mediate a variety of effector cell functions, including 
cellular proliferation, differentiation, and modulation of the 
immune response. Many cytokines activate receptor-associated 
Janus kinases (JAKs) that promote tyrosine phosphorylation of 
Bilayer membranes and transport models: 
Tom M Fyles 
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Jik Chin 
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Edited by Anne Dell, Barbara Imperiali and Larry 
McLaughlin 
Editorlai overview: 
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Anne Dell, Barbara Imperiali and Larry McLaughlin 
Chemical approaches to understanding base excision 
DNA repair 
Orlando D Scharer, Li Deng and Gregory l. Verdine 
Strocture functlon-studies of the Hammerhead RNA 
Sandeep Verma, Narendra K Vaish and Fritz Eckstein 
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Brian R Gibney, Franesc Rabansi and P Leslie Dutton 
Biosynthetic systems for nonribosomal peptide 
antibiotic assembly 
Henning D Mootz and Mohamed A Marahiel 
Synthetic methods of glycopeptide assembly and 
biological analysis of giycopeptide products 
Morton Meldal and Phaedria M St Hilaire 
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Ben de Kruijff 
Chain elongation In the isoprenoid biqnthetic 
pethway 
Brenda Kellog and C Dale Poulter 
Myobacterial cell walk structurr4 btosynthesis and 
sites of drug action 
Delphi Chatterjee 
signal transducers and activators of transcription (STAT) factors. 
Although JAK activation has been correlated with 
’ i 
the regulation of 
JAKI '02%AIETDKEYYTVKDDRDS'042 
JAKl and JAK3 
JAKB ='KLLPLGKDYYVVREPGQSse4 remains unclear. 
Furthermore, the 
relative roles of JAKl and JAK3 in the activation of STATS by 
interleukin-2 (IL-Z) remain poorly understood. The authors 
targeted two conserved tyrosine residues within the activation 
loop of the JAKl and JAK3 kinase domains for substitution with 
phenylalanines. In an overexpression system, the catalytic 
function of JAKl strictly required the presence of the first of 
980 Chemistry & Biology 1997, Vol4 No 12 
these tyrosines, Tyr1033. In contrast, JAK3 retained catalytic 
activity when either or both of the tyrosines were mutated. 
Analysis of JAKl/S chimeras showed that JAK activity was also 
controlled by intramolecular interactions involving the amino- 
terminal domain of the JA’K as well as by the inherent signaling 
properties of the kinase domain. The authors reconstituted IL- 
Z-dependent STATS induction in a cell line lacking detectable 
expression of JAKl and JAK3. Catalytically active versions of 
both JAKl and JAK3 must be present for effective induction of 
STATS. JAKl and JAK3 are differentially regulated by specific 
tyrosines within their respective activation loops and, the amino- 
terminal domain of JAK3 appears to contain regulatory 
sequences that modify the function of the kinase domain. 
Finally, both JAKl and JAK3 must retain catalytic function for 
IL-Z-induced STATS activation. 
6 October 1997, Research Paper, Current Biology* 
q Functional expression of the eotaxin receptor CCR3 
in T lymphocytes co-localizing with eosinophils. B 0 
Gerber, M P Zanni, M Uguccioni, M Loetscher, C R 
Mackay, W J Pichler, N Yawalkar, M Baggiolini and 
B Moser (1997). Cm. Biol. 7, 636-643. 
The chemokine eotaxin is produced at sites of allergic 
inflammation, binds selectively to the chemokine receptor 
CCR3 and attracts eosinophil and basophil leukocytes. 
Responses of T 
lymphocytes to 
eotaxin have not 
been reported so 
far. The authors 
have investigated 
the expression of 
CCR3 in T 
lymphocytes and 
analysed the 
properties and in 
vivo distribution of T lymphocytes expressing this receptor. 
They found that T lymphocytes co-localizing with eosinophils 
at sites of allergic inflammation express CCR3, suggesting that 
eotaxin/CCR3 represents a novel mechanism of T-lymphocyte 
recruitment. These cells are essential in allergic inflammation, 
as mice lacking mature T lymphocytes were insensitive to 
allergen challenge. Surface CCR3 may mark a subset of T 
lymphocytes that induce eosinophil mobilization and 
activation through local production of Th2-type cytokines. 
14 October 1997, Research Paper, Current Biology 
0 Translational attenuation mediated by an mRNA intron. 
Rowan E Chapman and Peter Walter (1997). Curr. Biol. 7, 
850-859. 
The unfolded protein response (UPR) is an intracellular 
signaling pathway that is activated by the accumulation of 
*Current Biology and folding & Design are published using a 
continuous publication system. The date given is the date that the paper 
appeared on the internet. You can access the World Wide Web site for 
all Current Biology Ltd journals via BioMedNet at http:llbiomednet.com. 
Distance effect 
I 
UPR activation is 
the regulated 
AAA splicing of HACI 
mRNA, which 
encodes Haclp, a 
Direct effect 
5’ 
I 
transcription factor 
dedicated to this 
AAA pathway. Haclp 
can be detected 
only when the 
spliced form of 
unfolded proteins in the endoplasmic reticulum (ER). The 
UPR results in an increase in transcription of ER-resident 
proteins that facilitate protein folding in the ER. A key 
regulatory step in 
HACl mRNA is produced; this was surprising because the 
unspliced HACI mRNA is equally stable in cells. The authors 
show that, in contrast to most other unspliced pre-mRNAs, the 
unspliced HACI mRNA is transported from the nucleus into 
the cytosol. Although the unspliced HAG’1 mRNA is 
associated with polyribosomes, no detectable protein is 
produced unless the intron is removed, indicating that the 
presence of the intron prevents mRNA translation. In this 
paper, the authors have shown that the H,4CI mRNA intron is 
both necessary and sufficient to prevent complete translation 
of polyribosome-associated mRNAs. This, to the knowledge of 
the authors, identifies a new way by which translation of a 
mRNA can be attenuated. 
17 October 1997, Research Paper, Current Biology 
0 Design of a synthetic MdmS-binding mini protein 
that activates the ~53 response in viwo. Angelika 
Bdttger, Volker BSttger, Alison Sparks, Wei-Li Liu, 
Stephanie F. Howard and David P Lane (1997). Curr. Biol. 
7,860-869. 
The transcriptional activation function of the ~53 tumour 
suppressor protein is induced by DNA damage and results in 
growth arrest and/or apoptotic responses. A key component of 
this response is the dramatic rise in p53 protein concentration 
resulting from an increase in the protein’s stability. Very 
recently, it has 
been suggested that 
interaction with the 
Mdm2 protein may 
target ~53 for rapid 
degradation. The 
authors have 
designed a gene 
encoding a small 
tightly to the p53-binding pocket on the Mdm2 protein. When 
introduced into cells containing low levels of wild-type ~53, the 
protein causes a striking accumulation of the endogenous ~53 
protein, activation of a p53-responsive reporter gene and cell- 
cycle arrest, mimicking the effects seen in these cells after 
exposure to ultraviolet or ionising radiation. Microinjection of a 
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monoclonal antibody to the p53-binding site on Mdm2 has a 
similar effect. The results demonstrate that the p53 response is 
constitutively regulated in normal cells by Mdm2 and that 
disruption of the interaction alone is sufficient to stabilise the 
p53 protein and activate the p53 response. The approach 
provides a powerful new method to activate p53 without 
causing DNA damage. More broadly, it establishes a general 
method for determining the biological consequences of the 
specific disruption of protein-protein interactions in cells. 
17 October 1997, Research Paper, Current Biology 
•i The phytofluors: a new class of fluorescent protein 
probes. John T Murphy and J Clark Lagarias (1997). Curr. 
Biol. 7, 870476. 
Biologically compatible fluorescent protein probes, particularly 
the self-assembling green fluorescent protein (GFP) from the 
jellyfish Aequorea Victoria, have revolutionized research in cell, 
molecular and developmental biology because they allow 
visualization of biochemical events in living cells. Additional 
fluorescent proteins that could be reconstituted in vivo while 
extending the useful wavelength range towards the orange and 
red regions of the 
light spectrum 
would increase the 
range of 
applications for 
fluorescent protein 
probes. Intensely 
orange fluorescent 
adducts, phyto- 
fluors, are sponta- 
neously formed 
upon incubation of 
recombinant plant 
phytochrome 
apoproteins with phycoerythrobilin, the linear tetrapyrrole 
precursor of the phycoerythrin chromophore. Phytofluors have 
large molar absorption coefficients, fluorescence quantum yields 
greater than 0.7, excellent photostability, stability over a wide 
range of pH, and can be reconstituted in living plant cells. The 
phytofluors are a new class of fluorophore that can potentially 
be produced upon bilin uptake by any living cell expressing an 
apophytochrome cDNA. Mutagenesis of the phytochrome 
apoprotein and/or alteration of the linear tetrapyrrole precursor 
by chemical synthesis are expected to yield new phytofluors 
that have fluorescence excitation and emission spectra spanning 
the visible to near-infrared light spectrum. 
17 October 1997, Research Paper, Current Sio/ogy 
0 Solution conformation of an essential region of the 
~53 transactivation domain. Maria Victoria E Botuyan, 
Jamil Momand and Yuan Chen (1997). Fold. Des. 2, 
331-342. 
The p53 tumor supressor protein responds to cellular stress, 
such as DNA damage. The peptide segment surrounding 
residues Let&? and Trp23 of the p53 transactivation domain 
plays a critical role in the transactivation activity of ~53. This 
region binds basal transcriptional components such as the 
TATA-box binding protein associated factors TAF,,40 and 
TAF,,60 as well as the Mdm2 and adenovirus type 5 ElB 55 
kDa oncoproteins. The structure of residues 14-28 of p53 was 
studied by nuclear magnetic resonance spectroscopy and found 
to prefer a two-b- 
turn structure 
stabilized by a 
hydrophobic cluster 
consisting of 
residues known to 
be important for 
transactivation and 
binding to p53- 
binding proteins. 
The structural 
propensity observed 
in the wild-type p53 
peptide is important for understanding the mechanism of 
transcriptional activation, because very few structural data are 
available on transactivation domains to date. The results should 
aid in the design of therapeutic agents that could competitively 
inhibit binding of p53 to the oncogene product Mdm2. 
22 October 1997, Research Paper, Folding & Design 
0 The structure of glycogen phosphorylase b with an 
alkyl-dihydropyridine-dicarboxylic acid compound, a 
novel and potent inhibitor. Spyros E Zographos, Nikos 
G Oikonomakos, Katerina E Tsitsanou, Demetrios D 
Leonidas, Evangelia D Chrysina, Vicky T Skamnaki, Hilmar 
Bischoff, Siegfried Goldmann, Kimberly A Watson and 
Louise N Johnson (1997). Structure 5, 1413-l 425. 
In muscle and liver, glycogen concentrations are regulated by 
the reciprocal activities of glycogen phosphorylase (GP) and 
glycogen synthase. An alkyl-dihydropyridine-dicarboxylic acid 
has been found to be a potent inhibitor of GP, and as such has 
potential to contribute to the regulation of glycogen 
metabolism in the 
non-insulin- 
dependent diabetes 
diseased state. The 
inhibitor has no 
structural similarity 
to the natural 
regulators of GP. 
The authors have 
carried out 
structural studies to 
elucidate the 
mechanism of inhibition. Kinetic studies with rabbit muscle 
glycogen phosphorylase b (GPb) show that the compound 
(-)(S)-3-isopropyl4-(2-chlorophenyl)-l,4-dihydro-l-ethyl-2- 
methyl-pyridine-3,5,6-tricarboxylate (Bay W1807) has a 
K,= 1.6 nM and is a competitive inhibitor with respect to AMP. 
The structure of the cocrystallised GPb-W1807 complex has 
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been determined. The high affinity of W1807 for GP appears 
to arise from the numerous nonpolar interactions made 
between the ligand and the protein. Its potency as an inhibitor 
results from the induced conformational changes that lock the 
enzyme in a conformation known as the T’ state. Allosteric 
enzymes, such as GP, offer a new strategy for structure-based 
drug design in which the allosteric site can be exploited. The 
results reported here may have important implications in the 
design of new therapeutic compounds. 
15 November 1997, Research Paper, Structure 
[? Structural foundation for the design of receptor 
antagonists targeting Escherichia co/i heat-labile 
enterotoxin. Ethan A Merritt, Steve Sarfaty, lngeborg K 
Feil and Wim G J HOI (1997). Structure 5, 1485-l 499. 
Esdzetichia co/i heat-labile enterotoxin (LT) is the causative 
agent of traveller’s diarrhoea, and it is also responsible for the 
deaths of hundreds of thousands of children per year in 
developing countries. LT is highly homologous in sequence, 
structure and function to cholera toxin (CT). Both toxins attack 
intestinal epithelial cells via specific binding to the branched 
pentasaccharide of ganglioside G,,, at the cell surface. A 
receptor-binding antagonist that blocked this interaction would 
potentially constitute a prophylactic drug conferring protection 
both against the severe effects of cholera itself and against the 
milder but more common disease caused by LT. Four 
derivatives of the 
simple sugar 
galactose, members 
of a larger series of 
receptor antagonists 
identified by 
computer modeling 
and competitive 
binding studies, 
have been co- 
crystallized with 
either the full LT 
AB, holotoxin or 
the LT B 
pentamer. The 
crystal structures 
have provided’ 
detailed views of 
the toxin in complex with each of the four antagonists: 
melibionic acid, lactulose, metanitrophenylgalactoside (MNPG) 
and thiodigalactoside (TDG). The bound conformations of 
these receptor antagonist compounds preserve the 
toxin-galactose interactions previously observed for toxin-sugar 
complexes, but gain additional favorable interactions. The 
highest affinity compound, MNPG, is notable in that it 
displaces a water molecule that is observed to be well-ordered 
in all other previous and current crystal structures of toxin- 
-sugar complexes. This could be a favorable entropic factor 
contributing to the increased affinity. The highest affinity 
members of the present set of antagonists (IMNPG and TDG) 
bury roughly half of the binding-site surface covered by the full 
receptor G,, pentasaccharide, despite being considerably 
smaller. This provides an encouraging basis for the creation of 
subsequent generations of derived compounds that can 
compete effectively with the natural receptor. 
15 November 1997, Research Paper Structure 
0 Crystal structure of ferrochelatase: the terminal 
enzyme in heme biosynthesis. Salam Al-Karadaghi, 
Mats Hansson, Stanislav Nikonov, Bodil Jansson and Lars 
Hederstedt (1997). Structure 5, 1501-l 510. 
The metallation of closed ring tetrapyrroles resulting in the 
formation of hemes, chlorophylls and vitamin B,, is catalyzed 
by specific enzymes called chelatases. Ferrochelatase catalyzes 
the terminal step in heme biosynthesis by inserting ferrous ion 
into protoporphyrin IX by a mechanism that is poorly 
understood. 
Mutations in the 
human gene for 
ferrochelatase can 
result in the 
disease 
erythropoietic 
protoporphyria, and 
a further 
understanding of 
the mechanism of 
this enzyme is 
therefore of clinical 
interest. No three- 
dimensional 
structure of a 
tetrapyrrole 
metallation enzyme 
has been available 
until now. The 
authors have 
determined the three-dimensional structure of Bacillus stlbrilis 
ferrochelatase. The position of invariant residues, shown 
previously to be important for activity, reveals the location of 
the porphyrin-binding cleft and the metallation site of the 
enzyme. Comparison of amino acid sequences of 
ferrochelatases from different sources shows that ferrochelatase 
seems to have a structurally conserved core region that is 
common to the enzyme from bacteria, plants and mammals. 
The structure provides the basis for the exploration of the 
function of ferrochelatase and for understanding the mechanism 
of metal insertion into organic molecules in biological systems. 
15 November 1997, Research Paper, Structure 
